Bluebird Bio reported $396.62M in Cash and Equivalent for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 80.03M 123.1M
Alnylam Pharmaceuticals ALNY:US $ 534.08M 285.89M
Amgen AMGN:US $ 6528M 1461M
Applied Genetic Technologies AGTC:US $ 67.85M 4.92M
Arrowhead Research ARWR:US $ 86.41M 5.18M
Avrobio Inc AVRO:US $ 161.66M 27.9M
Biomarin Pharmaceutical BMRN:US $ 605.44M 18.16M
Bluebird Bio BLUE:US $ 396.62M 5.84M
Immunogen IMGN:US $ 437.66M 41.09M
IONIS PHARMACEUT IONS:US $ 542.51M 326.68M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Nektar Therapeutics NKTR:US $ 25.22M 28.8M
Novartis NOVN:VX SF 12407M 5196M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M